Why the study?
Although studies substantiate the long-term safety and efficacy of the low-cost TTK Chitra heart valve prosthesis in India, it has been less commonly used in Nepal.
Case Report (n=1)
No
The TTK Chitra mechanical heart valve provides a hemodynamically stable and affordable option for mitral valve replacement in patients with rheumatic heart disease in developing countries.
Answers are grounded in this paper and cite their sources.
Case supports short-term stability of affordable TTK Chitra valve; leaves open need for larger studies before wider use in rheumatic disease.
TTK Chitra heart valve prosthesis (chvp), a tilting disc mechanical heart valve of low cost and proven efficacy, has been in use for the last 15 years in India. Although various studies substantiating its long-term safety and efficacy are available but is less commonly used in Nepal. The TTK Chitra heart valve has been developed and widely used in India.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2022) conducted a case report in Severe mitral stenosis (Rheumatic heart disease) (n=1). TTK Chitra heart valve prosthesis was evaluated on Hemodynamic performance.
Synapse has enriched 10 related papers. Consider them for comparative context: